![2-(5-amino-2,8,9-triazabicyclo[4.3.0]nona-1,3,5,7-tetraen-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol结构式](https://www.chemsrc.com/caspic/320/49834-61-9.png)
2-(5-amino-2,8,9-triazabicyclo[4.3.0]nona-1,3,5,7-tetraen-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol结构式
|
常用名 | 2-(5-amino-2,8,9-triazabicyclo[4.3.0]nona-1,3,5,7-tetraen-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol | 英文名 | 2-(5-amino-2,8,9-triazabicyclo[4.3.0]nona-1,3,5,7-tetraen-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol |
|---|---|---|---|---|
| CAS号 | 49834-61-9 | 分子量 | 266.25300 | |
| 密度 | 1.9g/cm3 | 沸点 | 646.6ºC at 760 mmHg | |
| 分子式 | C11H14N4O4 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 344.9ºC |
| 英文名 | 2-(4-aminopyrazolo[3,4-b]pyridin-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol |
|---|
| 密度 | 1.9g/cm3 |
|---|---|
| 沸点 | 646.6ºC at 760 mmHg |
| 分子式 | C11H14N4O4 |
| 分子量 | 266.25300 |
| 闪点 | 344.9ºC |
| 精确质量 | 266.10200 |
| PSA | 126.65000 |
| 折射率 | 1.834 |
|
~42%
2-(5-amino-2,8,... 49834-61-9 |
| 文献：Sanghvi; Larson; Willis; Robins; Revankar Journal of Medicinal Chemistry, 1989 , vol. 32, # 5 p. 945 - 951 |
|
~%
2-(5-amino-2,8,... 49834-61-9 |
| 文献：Sanghvi; Larson; Willis; Robins; Revankar Journal of Medicinal Chemistry, 1989 , vol. 32, # 5 p. 945 - 951 |
|
~%
2-(5-amino-2,8,... 49834-61-9 |
| 文献：Sanghvi; Larson; Willis; Robins; Revankar Journal of Medicinal Chemistry, 1989 , vol. 32, # 5 p. 945 - 951 |
|
~%
2-(5-amino-2,8,... 49834-61-9 |
| 文献：Sanghvi; Larson; Willis; Robins; Revankar Journal of Medicinal Chemistry, 1989 , vol. 32, # 5 p. 945 - 951 |
|
~%
2-(5-amino-2,8,... 49834-61-9 |
| 文献：Sanghvi; Larson; Willis; Robins; Revankar Journal of Medicinal Chemistry, 1989 , vol. 32, # 5 p. 945 - 951 |
|
~%
2-(5-amino-2,8,... 49834-61-9 |
| 文献：Sanghvi; Larson; Willis; Robins; Revankar Journal of Medicinal Chemistry, 1989 , vol. 32, # 5 p. 945 - 951 |
![(3aR,6R,6aR)-6-(((叔丁基二甲基硅烷基)氧基)甲基)-2,2-二甲基四氢呋喃并[3,4-d][1,3]二氧戊环-4-醇结构式](https://www.chemsrc.com/caspic/075/217309-46-1.png)
![4-氯-1H-吡唑并[3,4-B]吡啶结构式](https://www.chemsrc.com/caspic/394/29274-28-0.png)
